Tevogen (TVGN) Total Liabilities (2021 - 2026)

Tevogen (TVGN) has reported Total Liabilities for 6 consecutive years, with -$800.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 5916.54% year-over-year to -$800.0 million; the trailing twelve-month figure through Jun 2026 stood at -$800.0 million (down 5916.54% YoY), and the FY2025 full-year result was $12.6 million, up 24.49% from the prior year.
• Total Liabilities declined to -$800.0 million in Q2 2026 per TVGN's latest filing, from $14.8 million in the prior quarter.
• Across five years, Total Liabilities topped out at $99.9 million in Q4 2023 and bottomed at -$800.0 million in Q2 2026.
• Historically, Total Liabilities has averaged -$27.0 million across 5 years, with a median of $14.3 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Total Liabilities jumped 563.68% in 2023, then plunged 5916.54% in 2026.
• Over 5 years, Total Liabilities stood at $15.1 million in 2022, then surged by 563.68% to $99.9 million in 2023, then tumbled by 89.86% to $10.1 million in 2024, then advanced by 24.49% to $12.6 million in 2025, then sank by 6440.29% to -$800.0 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered -$800.0 million, $14.8 million, and $12.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.